Skip to main content
Top
Published in: Clinical Rheumatology 5/2008

01-05-2008 | Original Article

Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared

Authors: Chih-Lung Hou, Yi-Chan Tsai, Li-Chen Chen, Jing-Long Huang

Published in: Clinical Rheumatology | Issue 5/2008

Login to get access

Abstract

Systemic lupus erythematosus (SLE) patients had an increased susceptibility to tuberculosis (TB). The aim of this study was to investigate the prevalence and clinical characteristics of TB in SLE patients, with focus on the differences between pulmonary and extra-pulmonary TB. This is a retrospective study that reviewed the medical records of 3,179 SLE patients from 1985 to 2004. The diagnosis of TB was confirmed by one of the following: positive acid-fast bacillus (AFB) smear, positive culture of Mycobacterium tuberculosis from appropriate specimens, or a histopathologic finding of caseating granuloma on specimen. During the 20-year review period, TB was documented in 19 SLE patients, with 21 episodes. Ten of 21 episodes (47.6%) were pulmonary TB while the other 11 episodes (52.4%) were extra-pulmonary TB. Among extra-pulmonary TB, there were joint and cutaneous involvements in five, miliary in two, Pott’s disease in two, peritoneum in one, and spleen in one. The most common manifestations of TB were fever and cough. Delayed diagnosis and adverse effects of anti-TB therapy were observed in the extra-pulmonary TB group. While SLE patients commonly present with prolonged fever or chronic cough, tuberculosis infection should be taken into consideration.
Literature
1.
go back to reference Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492–1499PubMedCrossRef Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492–1499PubMedCrossRef
2.
go back to reference Tsao CH, Chen CY, Ou LS, Huang JL (2002) Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol 29:1214–1218PubMed Tsao CH, Chen CY, Ou LS, Huang JL (2002) Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol 29:1214–1218PubMed
3.
go back to reference Hung JJ, Ou LS, Lee WI, Huang JL (2005) Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32:40–43PubMed Hung JJ, Ou LS, Lee WI, Huang JL (2005) Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32:40–43PubMed
4.
go back to reference Wu KC, Yao TC, Yeh KW, Huang JL (2004) Osteomyelitis in patients with systemic lupus erythematosus. J Rheumatol 31:1340–1343PubMed Wu KC, Yao TC, Yeh KW, Huang JL (2004) Osteomyelitis in patients with systemic lupus erythematosus. J Rheumatol 31:1340–1343PubMed
5.
go back to reference Sayarlioglu M, Inang M, Kamali S et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274–278PubMedCrossRef Sayarlioglu M, Inang M, Kamali S et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274–278PubMedCrossRef
6.
go back to reference Paton NI (1997) Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 26:694–700PubMed Paton NI (1997) Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 26:694–700PubMed
7.
go back to reference Tam LS, Li EK, Wong SM, Szeto CC (2002) Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol 31:296–300PubMedCrossRef Tam LS, Li EK, Wong SM, Szeto CC (2002) Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol 31:296–300PubMedCrossRef
8.
go back to reference Balakrishnan C, Mangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Physicians India 46:682–683PubMed Balakrishnan C, Mangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Physicians India 46:682–683PubMed
9.
go back to reference Feng PH, Tan TH (1982) Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41:11–14PubMedCrossRef Feng PH, Tan TH (1982) Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41:11–14PubMedCrossRef
10.
go back to reference Victorio-Navarra ST, Dy EE, Arroyo CG, Torralba TP (1996) Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 26:628–634PubMedCrossRef Victorio-Navarra ST, Dy EE, Arroyo CG, Torralba TP (1996) Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 26:628–634PubMedCrossRef
11.
go back to reference Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482PubMedCrossRef Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482PubMedCrossRef
12.
go back to reference Noel V, Lortholary O, Casassus P et al (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60:1141–1144PubMedCrossRef Noel V, Lortholary O, Casassus P et al (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60:1141–1144PubMedCrossRef
13.
go back to reference Paton NI, Cheong IK, Kong NC, Segasothy M (1996) Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 89:531–538PubMed Paton NI, Cheong IK, Kong NC, Segasothy M (1996) Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 89:531–538PubMed
14.
go back to reference Hernandez-Cruz B, Sifuentes-Osornio J, Ponce-de-Leon RS, Ponce-de-Leon GA, Diaz-Jouanen E (1999) Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol 17:289–296 Hernandez-Cruz B, Sifuentes-Osornio J, Ponce-de-Leon RS, Ponce-de-Leon GA, Diaz-Jouanen E (1999) Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol 17:289–296
15.
go back to reference Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
16.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef
17.
18.
go back to reference Corett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009–10021CrossRef Corett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009–10021CrossRef
19.
go back to reference de Luis A, Pigrau C, Pahissa A, Fernandez F, Matinez-Vazquez JM (1990) Infections in 96 cases of systemic lupus erythematosus. Med Clin (Barc) 94:607–610 de Luis A, Pigrau C, Pahissa A, Fernandez F, Matinez-Vazquez JM (1990) Infections in 96 cases of systemic lupus erythematosus. Med Clin (Barc) 94:607–610
20.
go back to reference Gaitinde S, Pathan E, Sule A, Mittal G, Joshi VR (2002) Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis 61:251–253CrossRef Gaitinde S, Pathan E, Sule A, Mittal G, Joshi VR (2002) Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis 61:251–253CrossRef
21.
go back to reference Huang JL, Lin CJ, Hung IJ, Luo SF (1994) The morbidity and mortality associated with childhood onset systemic lupus erythematosus. Chang Gung Med J 17:113–120 Huang JL, Lin CJ, Hung IJ, Luo SF (1994) The morbidity and mortality associated with childhood onset systemic lupus erythematosus. Chang Gung Med J 17:113–120
22.
go back to reference Dessein PH, Gledhill RF, Rossouw DS (1988) Systemic lupus erythematosus in black South Africans. S Afr Med J 74:387–389PubMed Dessein PH, Gledhill RF, Rossouw DS (1988) Systemic lupus erythematosus in black South Africans. S Afr Med J 74:387–389PubMed
23.
go back to reference Rovensky J, Kovalancik M, Kristufek P et al (1996) Contribution to the problem of occurrence of tuberculosis in patients with systemic lupus erythematosus. Z Rheumatol 55:180–187PubMed Rovensky J, Kovalancik M, Kristufek P et al (1996) Contribution to the problem of occurrence of tuberculosis in patients with systemic lupus erythematosus. Z Rheumatol 55:180–187PubMed
24.
go back to reference Yun JE, Lee SW, Kim TH et al (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed Yun JE, Lee SW, Kim TH et al (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed
25.
go back to reference Small PM, Fujiwara RA PI (2001) Management of tuberculosis in the United States. N Engl J Med 345:189–200PubMedCrossRef Small PM, Fujiwara RA PI (2001) Management of tuberculosis in the United States. N Engl J Med 345:189–200PubMedCrossRef
26.
go back to reference Ilgazli A, Boyaci H, Basyigit I, Yildiz F (2004) Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res 35:435–441PubMedCrossRef Ilgazli A, Boyaci H, Basyigit I, Yildiz F (2004) Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res 35:435–441PubMedCrossRef
27.
go back to reference Division of Tuberculosis Control, BC Centre for Disease Control (1998) Annual Report. Vancouver, B.C., Canada: Centre for Disease Control Division of Tuberculosis Control, BC Centre for Disease Control (1998) Annual Report. Vancouver, B.C., Canada: Centre for Disease Control
28.
go back to reference Le Moing V, Leport C (1998) Infections and lupus. Rev Prat 48:637–642PubMed Le Moing V, Leport C (1998) Infections and lupus. Rev Prat 48:637–642PubMed
Metadata
Title
Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared
Authors
Chih-Lung Hou
Yi-Chan Tsai
Li-Chen Chen
Jing-Long Huang
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0741-8

Other articles of this Issue 5/2008

Clinical Rheumatology 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.